Propanoic acid, 3-[[17-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-3,6,9,12,15-pentaoxaheptadec-1-yl]oxy]- Chemical Properties

Boiling point:

809.5±65.0 °C(Predicted)

Density 

1.339±0.06 g/cm3(Predicted)

storage temp. 

2-8°C

pka

4.28±0.10(Predicted)

Propanoic acid, 3-[[17-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-3,6,9,12,15-pentaoxaheptadec-1-yl]oxy]- Usage And Synthesis

Uses

Protein degrader builiding block Pomalidomide-PEG₆-CO₂H enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand and a PEGylated crosslinker with pendant carboxylic acid for reactivity with an amine on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant carboxyl group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.

Propanoic acid, 3-[[17-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-3,6,9,12,15-pentaoxaheptadec-1-yl]oxy]-(2225148-49-0)Related Product Information

• POMALIDOMIDE-PEG2-CO2H
• Pomalidomide-PEG2-N3
• Pomalidomide-PEG4-azide
• Pomalidomide-PEG2-butyl iodide
• E3 Ligase Ligand-Linker Conjugates 22
• 4-((2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
• Pomalidomide-PEG4-CO2H
• E3 Ligase Ligand-Linker Conjugates 1
• Pomalidomide-PEG1-azide
• Pomalidomide-PEG5-CO2H
• POMALIDOMIDE-PEG1-CO2H
• Pomalidomide-O-C4-NH2
• Pomalidomide-PEG3-N3
• Pomalidomide-PEG6-butyl iodide
• Pomalidomide-PEG3-CO2H
• E3 ligase Ligand-Linker Conjugates 50
• Pomalidomide-PEG3-NH2
• POMALIDOMIDE-PEG2-ALKYNE